Cancer
JACKSONVILLE, Fla. — Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ-domain of GIPC1[...]
Latest stories
Neurosciences
April 18, 2026
Neurosciences
April 16, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community